<SEC-DOCUMENT>0001070081-20-000122.txt : 20200720
<SEC-HEADER>0001070081-20-000122.hdr.sgml : 20200720
<ACCEPTANCE-DATETIME>20200720073459
ACCESSION NUMBER:		0001070081-20-000122
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200717
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200720
DATE AS OF CHANGE:		20200720

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PTC THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001070081
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				043416587
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35969
		FILM NUMBER:		201035013

	BUSINESS ADDRESS:	
		STREET 1:		100 CORPORATE COURT
		CITY:			SOUTH PLAINFIELD
		STATE:			NJ
		ZIP:			07080-2449
		BUSINESS PHONE:		9082227000

	MAIL ADDRESS:	
		STREET 1:		100 CORPORATE COURT
		CITY:			SOUTH PLAINFIELD
		STATE:			NJ
		ZIP:			07080-2449

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PTC THERAPEUTICS INC
		DATE OF NAME CHANGE:	19980909
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8k72020.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:030FA004497E5506AF1FBA1450D953FB,x:2747b0393756450c977377b7af7fdd35-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2019-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2019-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2019-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2019-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2019-01-31" xmlns:lea="http://fasb.org/dis/lea/2019-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2019-01-31" xmlns:guar="http://fasb.org/dis/guar/2019-01-31" xmlns:ru="http://fasb.org/dis/ru/2019-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2019-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2019-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2019-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2019-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:cce="http://fasb.org/dis/cce/2019-01-31" xmlns:inv="http://fasb.org/dis/inv/2019-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:srt-std="http://fasb.org/srt-std/2019-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2019-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2019-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2019-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2019-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2019-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2019-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:re="http://fasb.org/dis/re/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2019-01-31" xmlns:invco="http://fasb.org/dis/invco/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2019-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2019-01-31" xmlns:currency-ent-dep="http://xbrl.sec.gov/currency-ent-dep/2019-01-31" xmlns:aro="http://fasb.org/dis/aro/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:srt-all="http://fasb.org/srt-all/2019-01-31" xmlns:codification-part="http://fasb.org/codification-part/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:ptct="http://www.ptcbio.com/20200717" xmlns:sec-re="http://fasb.org/dis/sec-re/2019-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2019-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2019-01-31" xmlns:equity="http://fasb.org/dis/equity/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:se="http://fasb.org/dis/se/2019-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2019-01-31" xmlns:edco="http://fasb.org/dis/edco/2019-01-31" xmlns:te="http://fasb.org/dis/te/2019-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2019-01-31" xmlns:hco="http://fasb.org/dis/hco/2019-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:dr="http://fasb.org/dis/dr/2019-01-31" xmlns:ero="http://fasb.org/dis/ero/2019-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2019-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2019-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2019-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2019-01-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2019-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2019-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2019-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2019-01-31" xmlns:soi="http://fasb.org/stm/soi/2019-01-31" xmlns:diha="http://fasb.org/dis/diha/2019-01-31" xmlns:debt="http://fasb.org/dis/debt/2019-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2019-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2019-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2019-01-31" xmlns:rd="http://fasb.org/dis/rd/2019-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2019-01-31" xmlns:eui="http://fasb.org/dis/eui/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ap="http://fasb.org/dis/ap/2019-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2019-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2019-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2019-01-31" xmlns:sr="http://fasb.org/dis/sr/2019-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2019-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2019-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2019-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2019-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2019-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2019-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2019-01-31" xmlns:oi="http://fasb.org/dis/oi/2019-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2019-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2019-01-31" xmlns:cc="http://fasb.org/dis/cc/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2019-01-31" xmlns:disops="http://fasb.org/dis/disops/2019-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:cn-part="http://fasb.org/cn-part/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2019-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2019-01-31" xmlns:ts="http://fasb.org/dis/ts/2019-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2019-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2019-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:ni="http://fasb.org/dis/ni/2019-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2019-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2019-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2019-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2019-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2019-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2019-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2019-01-31" xmlns:ir="http://fasb.org/dis/ir/2019-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2019-01-31" xmlns:foct="http://fasb.org/dis/foct/2019-01-31" xmlns:soc="http://fasb.org/stm/soc/2019-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2019-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2019-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2019-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:con="http://fasb.org/dis/con/2019-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2019-01-31" xmlns:eps="http://fasb.org/dis/eps/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2019-01-31" xmlns:pay="http://fasb.org/dis/pay/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:tin-part="http://fasb.org/tin-part/2019-01-31" xmlns:acec="http://fasb.org/dis/acec/2019-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2019-01-31" xmlns:nt="http://fasb.org/dis/nt/2019-01-31" xmlns:spc="http://fasb.org/stm/spc/2019-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2019-01-31" xmlns:ides="http://fasb.org/dis/ides/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2019-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:regop="http://fasb.org/dis/regop/2019-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2019-01-31" xmlns:com="http://fasb.org/stm/com/2019-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2019-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2019-01-31" xmlns:exch-ent-dep="http://xbrl.sec.gov/exch-ent-dep/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ei="http://fasb.org/dis/ei/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="D2020Q3RPI" name="dei:AmendmentFlag" id="Fact-C90D3AE434D55A5D8BAD4A46F5CA0987-wk-Fact-C90D3AE434D55A5D8BAD4A46F5CA0987" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q3RPI" name="dei:EntityCentralIndexKey" id="Fact-1642947DED3D5B2291908E3083316879-wk-Fact-1642947DED3D5B2291908E3083316879">0001070081</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="ptct-20200717.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="D2020Q3RPI">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001070081</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-07-17</xbrli:startDate>
			<xbrli:endDate>2020-07-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context></ix:resources></ix:header></div><div><a id="sEE12C950410257B998DC9E99C6470A71"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">WASHINGTON, D.C. 20549</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM </span><span><ix:nonNumeric id="d83763232e68-wk-Fact-B11A5479A2DF5921BE45362E4144884E" name="dei:DocumentType" contextRef="D2020Q3RPI"><span style="font-size:18pt;font-weight:bold;">8-K</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:18pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">CURRENT REPORT</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Date of Report (Date of earliest event reported):  </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d83763232e82-wk-Fact-4E2435078FEF5A058D3DB89755B967AD" name="dei:DocumentPeriodEndDate" contextRef="D2020Q3RPI" format="ixt:datemonthdayyearen">July 17, 2020</ix:nonNumeric></span></span></span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:18pt;"><span><ix:nonNumeric id="d83763232e85-wk-Fact-EFEE3054F80A581187EFE81E76F7674A" name="dei:EntityRegistrantName" contextRef="D2020Q3RPI"><span style="font-size:18pt;font-weight:bold;">PTC THERAPEUTICS, INC.</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:18pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Exact Name of Company as Specified in Charter)</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:677px;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:214px;"></td><td style="width:16px;"></td><td style="width:214px;"></td><td style="width:16px;"></td><td style="width:214px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d83763232e109-wk-Fact-1EDA72515FDF5618AAF66F6DDCDEAC28" name="dei:EntityIncorporationStateCountryCode" contextRef="D2020Q3RPI" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d83763232e119-wk-Fact-1990F259F78F526A87FC14D99ADCAE1D" name="dei:EntityFileNumber" contextRef="D2020Q3RPI">001-35969</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d83763232e129-wk-Fact-28D7768CF45A535298E28FE6C8E4F98C" name="dei:EntityTaxIdentificationNumber" contextRef="D2020Q3RPI">04-3416587</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(State or Other Jurisdiction</span></div><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">of Incorporation)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Commission</span></div><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">File Number)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(IRS Employer</span></div><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Identification No.)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:517px;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:141px;"></td><td style="width:114px;"></td><td style="width:33px;"></td><td style="width:228px;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d83763232e181-wk-Fact-55CBF53835425A01A4976AD8310E4894" name="dei:EntityAddressAddressLine1" contextRef="D2020Q3RPI">100 Corporate Court</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d83763232e202-wk-Fact-D5AFA703FDD35DD3961429381F2A40EC" name="dei:EntityAddressCityOrTown" contextRef="D2020Q3RPI">South Plainfield,</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d83763232e207-wk-Fact-B18623E59D4F56E3AB06E6156895C9B1" name="dei:EntityAddressStateOrProvince" contextRef="D2020Q3RPI">NJ</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d83763232e217-wk-Fact-F4579CEAE9145C54AAB13594F5A29D5F" name="dei:EntityAddressPostalZipCode" contextRef="D2020Q3RPI">07080</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Address of Principal Executive Offices)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Zip Code)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Registrant&#8217;s telephone number, including area code: </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d83763232e244-wk-Fact-389891E702785EDB86EBA778A544C2EE" name="dei:CityAreaCode" contextRef="D2020Q3RPI">(908)</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span><span><ix:nonNumeric id="d83763232e248-wk-Fact-FB30F253968359D08E1499D8C14E73A1" name="dei:LocalPhoneNumber" contextRef="D2020Q3RPI"><span style="font-weight:bold;">222-7000</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Not applicable</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">see</span><span style="font-family:inherit;font-size:10pt;"> General Instruction A.2. below):</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span><ix:nonNumeric id="d83763232e269-wk-Fact-463F07D7FE795C69808165E05B9C1DA3" name="dei:WrittenCommunications" contextRef="D2020Q3RPI" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:5pt;">    </span><span style="font-family:inherit;font-size:10pt;"> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span><ix:nonNumeric id="d83763232e279-wk-Fact-F9DB1736FA3C5DA6A2F0893C14B33ADC" name="dei:SolicitingMaterial" contextRef="D2020Q3RPI" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:5pt;">    </span><span style="font-family:inherit;font-size:10pt;"> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span><ix:nonNumeric id="d83763232e289-wk-Fact-1656851AA8415AF78E4CD008246CC82C" name="dei:PreCommencementTenderOffer" contextRef="D2020Q3RPI" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:5pt;">    </span><span style="font-family:inherit;font-size:10pt;"> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span><ix:nonNumeric id="d83763232e299-wk-Fact-A77CA685D40750FDB5C79BF4F88086B4" name="dei:PreCommencementIssuerTenderOffer" contextRef="D2020Q3RPI" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:5pt;">    </span><span style="font-family:inherit;font-size:10pt;"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:18%;"></td><td style="width:41%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Title of each class</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Trading Symbol(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d83763232e341-wk-Fact-49094D55799A5796A424D6AE1C1FC172" name="dei:Security12bTitle" contextRef="D2020Q3RPI">Common Stock, $0.001 par value per share</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d83763232e346-wk-Fact-13CDABD9EC2B5DEE860325B10C6CB1B7" name="dei:TradingSymbol" contextRef="D2020Q3RPI">PTCT</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d83763232e351-wk-Fact-3CBBB0143C9256BFAF13A4E61C68CBAC" name="dei:SecurityExchangeName" contextRef="D2020Q3RPI" format="ixt-sec:exchnameen">Nasdaq Global Select Market</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Emerging growth company&#160;&#160;&#160;&#160;</span><span><ix:nonNumeric id="d83763232e361-wk-Fact-AE7FCE6B39E55E688E1916F734727D5E" name="dei:EntityEmergingGrowthCompany" contextRef="D2020Q3RPI" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;  </span><span style="font-family:Wingdings;font-size:10pt;">o</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s48B03261302D5CA68C2576A195017E70"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 1.01.  Entry into a Material Definitive Agreement.</span></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On July 17, 2020, PTC Therapeutics, Inc. (the &#8220;Company&#8221;), RPI 2019 Intermediate Finance Trust (&#8220;RPI&#8221;), and, for the limited purposes set forth in the agreement, Royalty Pharma PLC, entered into a Royalty Purchase Agreement (the &#8220;Royalty Purchase Agreement&#8221;).  Pursuant to the Royalty Purchase Agreement, the Company sold to RPI 42.933% (the &#8220;Assigned Royalty Payment&#8221;) of the Company&#8217;s right to receive sales-based royalty payments (the &#8220;Royalty&#8221;) on worldwide net sales of Roche&#8217;s risdiplam product and any other product (the &#8220;Products&#8221;) developed pursuant to the License and Collaboration Agreement (the &#8220;License Agreement&#8221;), dated as of November 23, 2011, by and among the Company, F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc. (together with F. Hoffman-La Roche Ltd, &#8220;Roche&#8221;), and, for the limited purposes set forth therein, the Spinal Muscular Atrophy Foundation (the &#8220;SMA Foundation&#8221;) under the SMA program, which is a collaboration among the Company, Roche and the SMA Foundation. In consideration for the sale of the Assigned Royalty Payments, RPI paid the Company $650.0 million in cash consideration. The Company will retain a 57.067% interest in the Royalty and all economic rights to receive the remaining potential regulatory and sales milestone payments under the License Agreement, which milestone payments equal approximately $400 million in the aggregate.  </span></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under the Royalty Purchase Agreement, and in connection with its sale of the Assigned Royalty Payments, the Company has agreed to specified negative and affirmative covenants with respect to the exercise of its rights under the License Agreement, including the Company&#8217;s right to amend, modify, assign or terminate the License Agreement.  The Company has agreed not to exercise its rights under the License Agreement in any manner that would be expected to adversely impact the Royalty or the Products.  The Company must also enforce the terms of the License Agreement as RPI reasonably requests in the event of a breach of the License Agreement by Roche or the SMA Foundation.  Subject to the satisfaction of certain conditions, the Company has also agreed to consult with RPI or act at RPI&#8217;s direction with respect to the Company&#8217;s exercise of its rights to enforce, defend, prosecute and maintain intellectual property rights under the License Agreement.  Subject to certain customary exceptions, the Company has agreed not to grant a security interest in its interest in the License Agreement, the Products or the patent rights that cover the Products.  The Royalty Purchase Agreement also contains representations and warranties, covenants and other negotiated provisions, including information rights and confidentiality obligations, customary for transactions of this nature.  The Royalty Purchase Agreement will terminate 60 days following the earlier of the date on which Roche is no longer obligated to make any payments of the Royalty pursuant to the License Agreement and the date on which RPI has received one billion three hundred million U.S. dollars in respect of the Assigned Royalty Payments.</span></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If, in the event of a termination of the License Agreement by Roche for convenience or by the Company for Roche&#8217;s material breach or patent challenge and the Company is then the owner of a majority of the Royalty based on consensus projections of the value of the Royalty and the Company has not otherwise undergone a change of control, the Company will have sole discretion with respect to the continued commercialization of the Products pursuant to the rights provided to the Company upon such termination of the License Agreement.  In the event that the Company is not the owner of a majority of the Royalty based on consensus projections of the value of the Royalty, or if the Company has undergone a change of control, then, upon termination of the License Agreement by Roche for convenience or by the Company for Roche&#8217;s material breach or patent challenge, (1) the Company will have the first right to commercialize the Products pursuant to the rights provided to the Company upon such termination of the License Agreement and (2) if the Company does not elect to commercialize the Products, RPI will have the right to direct the Company to commercialize the Products pursuant to the rights provided to the Company upon such termination of the License Agreement, including by negotiating a license or sublicense with one or more third parties to commercialize a Product that has obtained regulatory approval.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The foregoing description of the Royalty Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the complete text of the Royalty Purchase Agreement, which will be filed as an exhibit to the Company&#8217;s quarterly report on Form 10-Q for the fiscal quarter ending June 30, 2020. </span></div><div style="line-height:120%;padding-top:24px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;7.01. Regulation FD Disclosure. </span></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On July 20, 2020, the Company issued a press release in which it announced the closing of the Royalty Purchase Agreement. A copy of the press release is attached to this Current Report on Form 8-K (this &#8220;Report&#8221;) as Exhibit 99.1 and is incorporated by reference into this Item 7.01.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The information set forth in or incorporated by reference into this Item 7.01, including Exhibit 99.1, shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01. </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Statements and Exhibits.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(d) Exhibits</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.8984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:17%;"></td><td style="width:6%;"></td><td style="width:77%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit No.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">99.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a2020-07x20ptctroyalty.htm"><span style="font-family:inherit;font-size:10pt;">Press Release, dated July 20, 2020, issued by PTC Therapeutics, Inc.</span></a></div><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">104</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:174%;padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cautionary Statement Concerning Forward Looking Statements</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">This Report contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this Report, other than those of historical fact, are forward-looking statements, including statements regarding: the future expectations, plans and prospects for the Company; advancement of the Company's joint collaboration program in SMA, including any potential regulatory submissions, regulatory approvals or commercial prospects; the Company's strategy, future operations, future financial position, future revenues and projected costs; the Company&#8217;s expected use of proceeds from the agreement with RPI; potential royalties and potential regulatory and sales milestone payments; and the objectives of management.&#160; Other forward-looking statements may be identified by the words &#8220;guidance&#8221;, &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;target,&#8221; &#8220;potential,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;continue,&#8221; and similar expressions.&#160; The Company&#8217;s actual results, performance or achievements could differ materially from those expressed or implied by forward-looking statements it makes as a result of a variety of risks and uncertainties, including those related to: the enrollment, conduct, and results of studies under the SMA program and events during, or as a result of, the studies that could delay or prevent further development under the SMA program, including any potential regulatory submissions and potential commercialization with regard to risdiplam; the eligible patient base and commercial potential of risdiplam or any of the Company&#8217;s other product candidates; and the factors discussed in the &#8220;Risk Factors&#8221; section of the Company&#8217;s most recent Quarterly Report on Form&#160;10-Q and Annual Report on Form&#160;10-K as well as any updates to these risk factors filed from time to time in the Company&#8217;s other filings with the Securities and Exchange Commission.  You are urged to carefully consider all such factors.&#160;As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that any product or product candidate will receive or maintain regulatory approval in any territory, or prove to be commercially successful, including risdiplam.  The forward-looking statements contained herein represent the Company&#8217;s views only as of the date of this Report and the Company does not undertake or plan to update or revise any such forward-looking statements to reflect actual results or changes in plans, prospects, assumptions, estimates or projections, or other circumstances occurring after the date of this Report except as required by law. All website addresses given in this Report or incorporated herein by reference are for information only and are not intended to be an active link or to incorporate any website information into this Report.</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Signature</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:56%;"></td><td style="width:6%;"></td><td style="width:38%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">PTC Therapeutics, Inc.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Date: July 20, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">By:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">/s/ Mark Boulding</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Name:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Mark Boulding</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Title:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Executive Vice President and Chief Legal Officer</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a2020-07x20ptctroyalty.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s27C7F81442A23A0F3C5E69D28B2C941B"></a></div><div><div style="line-height:120%;text-align:right;text-indent:624px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT 99.1</font></div><div style="line-height:120%;text-align:left;"><img src="a20200720ptctroyaltyd_image1.gif" alt="a20200720ptctroyaltyd_image1.gif" style="font-weight:bold;height:62px;width:102px;"></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">PTC Therapeutics Announces Agreement to Monetize a Portion of the Risdiplam Royalty Stream for $650 Million </font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">- Strategic partnership with Royalty Pharma plc. enables PTC to strengthen and advance its diversified rare disorders portfolio &#8211; </font></div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">&#32;- Conference call scheduled for 8:30 am ET &#8211;</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">SOUTH PLAINFIELD, N.J., July 20, 2020</font><font style="font-family:Arial;font-size:10pt;">&#32;&#8211; PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced an agreement to monetize a portion of the risdiplam royalty stream for $650 million from Royalty Pharma plc. The capital from the collaboration will enable PTC to further develop and expand its innovative rare disorder portfolio, particularly its validated splicing, Bio-e and gene therapy platforms.</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8220;The discovery, development and expected commercialization of risdiplam exemplifies PTC&#8217;s strengths in novel scientific approaches to diseases with high unmet needs can generate value for the benefit of all of our stakeholders,&#8221; said Stuart W. Peltz, Ph.D., Chief Executive Officer of PTC Therapeutics. &#8220;Today&#8217;s announcement of our strategic partnership with Royalty Pharma brings forward significant, non-dilutive capital to drive further innovation and growth across our robust and diverse rare disorder portfolio.&#8221;</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Under the terms of the royalty purchase agreement, PTC Therapeutics will receive $650 million in upfront cash from Royalty Pharma in return for approximately 43% of the risdiplam royalties, up to a specified amount. PTC Therapeutics maintains the majority of the risdiplam royalty stream and retains all economics associated with up to $400 million in remaining regulatory and sales milestones.</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Pablo Legorreta, Royalty Pharma&#8217;s Founder and Chief Executive Officer, stated, &#8220;Risdiplam is consistent with our focus on high value, differentiated therapeutics addressing diseases with high unmet medical need. We recognize the value and importance of an oral therapy for the treatment of all types of SMA. We are delighted to partner with PTC and to help fund their innovative pipeline of treatments for rare diseases.&#8221; </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Wilmer Cutler Pickering Hale and Dorr LLP acted as legal advisor to PTC Therapeutics on the transaction. Goodwin Proctor, Dechert and Maiwald acted as legal advisors to Royalty Pharma.</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The risdiplam New Drug Application (NDA) for the treatment of Types 1, 2 and 3 spinal muscular atrophy (SMA) is under Priority Review by the U.S Food and Drug Administration, with a PDUFA date of August 24, 2020. A Marketing Authorization Application (MAA) is planned to be submitted to the European Medicines Agency (EMA), as well as filings in other international markets. The risdiplam SMA program is a collaboration between PTC, the SMA Foundation, and Roche.</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10.5pt;"><font style="font-family:Arial;font-size:10.5pt;background-color:#ffffff;color:#333333;font-weight:bold;">Today's Conference Call:</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">Today's conference call will take place at 8:30 am ET and can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 3492277. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at www.ptcbio.com. A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the PTC&#8217;s website for 30 days following the call.</font></div><div style="line-height:138%;text-align:left;font-size:10.5pt;"><font style="font-family:Arial;font-size:10.5pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:138%;text-align:left;font-size:10.5pt;"><font style="font-family:Arial;font-size:10.5pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10.5pt;"><font style="font-family:Arial;font-size:10.5pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">About Risdiplam </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Risdiplam is an investigational survival motor neuron 2 (SMN2) splicing modifier for SMA and is an orally administered liquid. It is designed to increase and sustain SMN protein levels both throughout the central nervous system and in peripheral tissues of the body. Risdiplam is being studied in the broadest clinical trial program in SMA, with patients ranging from birth to 60 years old, and includes patients previously treated with other SMA-targeting therapies. The clinical trial population represents the diverse, real-world spectrum of people living with this disease. The risdiplam clinical development program was designed with the aim of enabling access for all appropriate patients.</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">About PTC Therapeutics, Inc.</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. To learn more about PTC, please visit us at www.ptcbio.com</font><font style="font-family:Arial;font-size:10pt;color:#0563c1;">&#32;</font><font style="font-family:Arial;font-size:10pt;">and follow us on Facebook, on Twitter at @PTCBio, and on LinkedIn.</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:156%;padding-bottom:18px;text-align:left;font-size:10.5pt;"><font style="font-family:Arial;font-size:10.5pt;background-color:#ffffff;color:#333333;font-weight:bold;">For More Information: <br>Investors:</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10.5pt;background-color:#ffffff;color:#333333;">Alex Kane <br>+1 (908) 912-9643</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10.5pt;background-color:#ffffff;">akane@ptcbio.com</font></div><div style="line-height:156%;padding-bottom:18px;text-align:left;font-size:10.5pt;"><font style="font-family:Arial;font-size:10.5pt;background-color:#ffffff;color:#333333;font-weight:bold;">Media:</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10.5pt;background-color:#ffffff;color:#333333;">Jane Baj <br>+1 (908) 912-9167</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10.5pt;background-color:#ffffff;">jbaj@ptcbio.com</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:10.5pt;"><font style="font-family:Arial;font-size:10.5pt;color:#333333;font-weight:bold;">Forward Looking Statements:</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this release, other than statements of historical fact, are forward-looking statements, including statements regarding: the future expectations, plans and prospects for PTC; advancement of PTC's joint collaboration program in SMA, including any potential regulatory submissions, regulatory approvals or commercial prospects; PTC's strategy, future operations, future financial position, future revenues and, projected costs; PTC&#8217;s expected use of proceeds from the agreement with Royalty Pharma; potential royalties and potential regulatory and sales milestone payments; and the objectives of management. Other forward-looking statements may be identified by the words "guidance", "plan," "anticipate," "believe," "estimate," "expect," "intend," "may," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions.</font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">PTC's actual results, performance or achievements could differ materially from those expressed or implied by forward-looking statements it makes as a result of a variety of risks and uncertainties, including </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">those related to: the enrollment, conduct, and results of studies under the SMA collaboration and events during, or as a result of, the studies that could delay or prevent further development under the program, including any potential regulatory submissions and potential commercialization with regards to risdiplam; the eligible patient base and commercial potential of risdiplam or any of PTC's other product candidates; and the factors discussed in the "Risk Factors" section of PTC's most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K, as well as any updates to these risk factors filed from time to time in PTC's other filings with the SEC. You are urged to carefully consider all such factors.</font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that any product or product candidate will receive or maintain regulatory approval in any territory, or prove to be commercially successful, including risdiplam. </font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The forward-looking statements contained herein represent PTC's views only as of the date of this press release and PTC does not undertake or plan to update or revise any such forward-looking statements to reflect actual results or changes in plans, prospects, assumptions, estimates or projections, or other circumstances occurring after the date of this press release except as required by law.</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">###</font></div><div><br></div><div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ptct-20200717.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ptcbio.com/20200717" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ptct="http://www.ptcbio.com/20200717" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ptct-20200717_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ptct-20200717_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ptct-20200717_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ptct-20200717_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="CoverPageDocument" roleURI="http://www.ptcbio.com/role/CoverPageDocument">
        <link:definition>0001000 - Document - Cover Page Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="ptct_CoverpageAbstract" name="CoverpageAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>ptct-20200717_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.ptcbio.com/role/CoverPageDocument" xlink:href="ptct-20200717.xsd#CoverPageDocument" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.ptcbio.com/role/CoverPageDocument" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>ptct-20200717_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.ptcbio.com/role/CoverPageDocument" xlink:href="ptct-20200717.xsd#CoverPageDocument" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.ptcbio.com/role/CoverPageDocument" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>ptct-20200717_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_ptct_CoverpageAbstract_9F9EA1EE689BFAAE34CB12EB78562B6C_label_en-US" xlink:label="lab_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">cover page [Abstract]</link:label>
    <link:label id="lab_ptct_CoverpageAbstract_9F9EA1EE689BFAAE34CB12EB78562B6C_documentation_en-US" xlink:label="lab_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">cover page [Abstract]</link:label>
    <link:loc xlink:href="ptct-20200717.xsd#ptct_CoverpageAbstract" xlink:label="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="lab_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_C4517B94B84052FE32B512EB785B4079_terseLabel_en-US" xlink:label="lab_dei_DocumentType_5F215370287B5B7DBC0A90CEF1156655" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_C4517B94B84052FE32B512EB785B4079_label_en-US" xlink:label="lab_dei_DocumentType_5F215370287B5B7DBC0A90CEF1156655" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5F215370287B5B7DBC0A90CEF1156655" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_5F215370287B5B7DBC0A90CEF1156655" xlink:to="lab_dei_DocumentType_5F215370287B5B7DBC0A90CEF1156655" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_0E83231B49EC1FE81A3612EB785BBF36_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_FA1E019E7D0D53C399F97458560F9C6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_0E83231B49EC1FE81A3612EB785BBF36_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_FA1E019E7D0D53C399F97458560F9C6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_FA1E019E7D0D53C399F97458560F9C6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_FA1E019E7D0D53C399F97458560F9C6B" xlink:to="lab_dei_DocumentPeriodEndDate_FA1E019E7D0D53C399F97458560F9C6B" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_C596222BA97ACDF1A10B12EB785B6491_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_1DDB92DF502F5440B5944E0F37A3C5FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_C596222BA97ACDF1A10B12EB785B6491_label_en-US" xlink:label="lab_dei_EntityRegistrantName_1DDB92DF502F5440B5944E0F37A3C5FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1DDB92DF502F5440B5944E0F37A3C5FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_1DDB92DF502F5440B5944E0F37A3C5FC" xlink:to="lab_dei_EntityRegistrantName_1DDB92DF502F5440B5944E0F37A3C5FC" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_F7E76C8EB6B2A429763012EB785A74D9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_FCBA22BA1CF15DE8A652609784994324" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_F7E76C8EB6B2A429763012EB785A74D9_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_FCBA22BA1CF15DE8A652609784994324" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_FCBA22BA1CF15DE8A652609784994324" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_FCBA22BA1CF15DE8A652609784994324" xlink:to="lab_dei_EntityIncorporationStateCountryCode_FCBA22BA1CF15DE8A652609784994324" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_E7EA6DB36C0F561D720212EB7B8131CB_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_E10299A9C27B509AAA1D616F8C3DB4D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contained File Information, File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_E7EA6DB36C0F561D720212EB7B8131CB_label_en-US" xlink:label="lab_dei_EntityFileNumber_E10299A9C27B509AAA1D616F8C3DB4D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_E10299A9C27B509AAA1D616F8C3DB4D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_E10299A9C27B509AAA1D616F8C3DB4D8" xlink:to="lab_dei_EntityFileNumber_E10299A9C27B509AAA1D616F8C3DB4D8" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_E3123AAC3A41E48A1A9712EB785C4170_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_A84695F313935184A0C191D04F69827E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_E3123AAC3A41E48A1A9712EB785C4170_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_A84695F313935184A0C191D04F69827E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_A84695F313935184A0C191D04F69827E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_A84695F313935184A0C191D04F69827E" xlink:to="lab_dei_EntityTaxIdentificationNumber_A84695F313935184A0C191D04F69827E" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_DDE7C637B1DE93E587D112EB785A5F77_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_6DC05BCE30565BAA8292BE951FDDDD74" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_DDE7C637B1DE93E587D112EB785A5F77_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_6DC05BCE30565BAA8292BE951FDDDD74" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_6DC05BCE30565BAA8292BE951FDDDD74" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_6DC05BCE30565BAA8292BE951FDDDD74" xlink:to="lab_dei_EntityAddressAddressLine1_6DC05BCE30565BAA8292BE951FDDDD74" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_592048EF44AAE536846012EB785C0C8F_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_43C5E8CBD19C5308B80567C9E3CCC790" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_592048EF44AAE536846012EB785C0C8F_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_43C5E8CBD19C5308B80567C9E3CCC790" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_43C5E8CBD19C5308B80567C9E3CCC790" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_43C5E8CBD19C5308B80567C9E3CCC790" xlink:to="lab_dei_EntityAddressCityOrTown_43C5E8CBD19C5308B80567C9E3CCC790" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_D134AAF98F8970CE5DA412EB785C86A7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_BE97AEC212F650519C4C4F3C7A3C9D62" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_D134AAF98F8970CE5DA412EB785C86A7_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_BE97AEC212F650519C4C4F3C7A3C9D62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_BE97AEC212F650519C4C4F3C7A3C9D62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_BE97AEC212F650519C4C4F3C7A3C9D62" xlink:to="lab_dei_EntityAddressStateOrProvince_BE97AEC212F650519C4C4F3C7A3C9D62" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_3A88E27A4B92A3EB914412EB785C141A_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_85EB4064504758E9BB7C62892908B760" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3A88E27A4B92A3EB914412EB785C141A_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_85EB4064504758E9BB7C62892908B760" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_85EB4064504758E9BB7C62892908B760" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_85EB4064504758E9BB7C62892908B760" xlink:to="lab_dei_EntityAddressPostalZipCode_85EB4064504758E9BB7C62892908B760" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_1AEC18E92172051E527C12EB785C731C_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_519CE492CA8650C58BEB057A1E345973" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_1AEC18E92172051E527C12EB785C731C_label_en-US" xlink:label="lab_dei_CityAreaCode_519CE492CA8650C58BEB057A1E345973" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_519CE492CA8650C58BEB057A1E345973" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_519CE492CA8650C58BEB057A1E345973" xlink:to="lab_dei_CityAreaCode_519CE492CA8650C58BEB057A1E345973" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_5A3B1F056BEACDAA3FC312EB785D41F0_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_57780AC224765909A105821B1B7B334A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_5A3B1F056BEACDAA3FC312EB785D41F0_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_57780AC224765909A105821B1B7B334A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_57780AC224765909A105821B1B7B334A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_57780AC224765909A105821B1B7B334A" xlink:to="lab_dei_LocalPhoneNumber_57780AC224765909A105821B1B7B334A" xlink:type="arc" />
    <link:label id="lab_dei_WrittenCommunications_DCE23CB8DE201B588EA312EB785DBCD6_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications_665ED0B097AB54B28C7E52E1EF69F5DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_DCE23CB8DE201B588EA312EB785DBCD6_label_en-US" xlink:label="lab_dei_WrittenCommunications_665ED0B097AB54B28C7E52E1EF69F5DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_665ED0B097AB54B28C7E52E1EF69F5DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications_665ED0B097AB54B28C7E52E1EF69F5DF" xlink:to="lab_dei_WrittenCommunications_665ED0B097AB54B28C7E52E1EF69F5DF" xlink:type="arc" />
    <link:label id="lab_dei_SolicitingMaterial_760B757C59FA279516CD12EB785D2D23_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial_749E45849AF25442841169D3147AD19F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_760B757C59FA279516CD12EB785D2D23_label_en-US" xlink:label="lab_dei_SolicitingMaterial_749E45849AF25442841169D3147AD19F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_749E45849AF25442841169D3147AD19F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial_749E45849AF25442841169D3147AD19F" xlink:to="lab_dei_SolicitingMaterial_749E45849AF25442841169D3147AD19F" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementTenderOffer_344CB19EC791150E96E912EB785DB49A_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_603F63842A045E0FA8AE0AE8EBA52798" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_344CB19EC791150E96E912EB785DB49A_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_603F63842A045E0FA8AE0AE8EBA52798" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_603F63842A045E0FA8AE0AE8EBA52798" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer_603F63842A045E0FA8AE0AE8EBA52798" xlink:to="lab_dei_PreCommencementTenderOffer_603F63842A045E0FA8AE0AE8EBA52798" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_59137A62338E67AAB28C12EB785D6654_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_0DDAF72504015082A4DA8B036BFB4040" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_59137A62338E67AAB28C12EB785D6654_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_0DDAF72504015082A4DA8B036BFB4040" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_0DDAF72504015082A4DA8B036BFB4040" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer_0DDAF72504015082A4DA8B036BFB4040" xlink:to="lab_dei_PreCommencementIssuerTenderOffer_0DDAF72504015082A4DA8B036BFB4040" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_001777A8A6AF6538D2A412EB7859C521_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_61CCFF7A09715A84B6CC0379F1171755" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_001777A8A6AF6538D2A412EB7859C521_label_en-US" xlink:label="lab_dei_Security12bTitle_61CCFF7A09715A84B6CC0379F1171755" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_61CCFF7A09715A84B6CC0379F1171755" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_61CCFF7A09715A84B6CC0379F1171755" xlink:to="lab_dei_Security12bTitle_61CCFF7A09715A84B6CC0379F1171755" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_B80EC5FA2E5A9146AE5012EB785D4F73_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_F77B6C56343A58DDA2587B9BC15A9E82" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_B80EC5FA2E5A9146AE5012EB785D4F73_label_en-US" xlink:label="lab_dei_TradingSymbol_F77B6C56343A58DDA2587B9BC15A9E82" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_F77B6C56343A58DDA2587B9BC15A9E82" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_F77B6C56343A58DDA2587B9BC15A9E82" xlink:to="lab_dei_TradingSymbol_F77B6C56343A58DDA2587B9BC15A9E82" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_BD2611354DB294EA551E12EB785E1FBF_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_58B4508CE80F587FA1011C043DA9164B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_BD2611354DB294EA551E12EB785E1FBF_label_en-US" xlink:label="lab_dei_SecurityExchangeName_58B4508CE80F587FA1011C043DA9164B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_58B4508CE80F587FA1011C043DA9164B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_58B4508CE80F587FA1011C043DA9164B" xlink:to="lab_dei_SecurityExchangeName_58B4508CE80F587FA1011C043DA9164B" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_273F49BF87E829DB473712EB785EE2F6_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_9680654BD43050C3A3B67BB10D25D0B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_273F49BF87E829DB473712EB785EE2F6_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_9680654BD43050C3A3B67BB10D25D0B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_9680654BD43050C3A3B67BB10D25D0B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_9680654BD43050C3A3B67BB10D25D0B4" xlink:to="lab_dei_EntityEmergingGrowthCompany_9680654BD43050C3A3B67BB10D25D0B4" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_FB2DC3B7252F22BA459212EB785B3EDD_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_18FCE9B3BA665004BEF068674A12C68F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_FB2DC3B7252F22BA459212EB785B3EDD_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_18FCE9B3BA665004BEF068674A12C68F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_18FCE9B3BA665004BEF068674A12C68F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_18FCE9B3BA665004BEF068674A12C68F" xlink:to="lab_dei_EntityCentralIndexKey_18FCE9B3BA665004BEF068674A12C68F" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_32233D09D70BAE14723212EB785B60EE_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_DA3C3D9CDA815E978D5AA2B68E622AD4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_32233D09D70BAE14723212EB785B60EE_label_en-US" xlink:label="lab_dei_AmendmentFlag_DA3C3D9CDA815E978D5AA2B68E622AD4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_DA3C3D9CDA815E978D5AA2B68E622AD4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_DA3C3D9CDA815E978D5AA2B68E622AD4" xlink:to="lab_dei_AmendmentFlag_DA3C3D9CDA815E978D5AA2B68E622AD4" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>ptct-20200717_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.ptcbio.com/role/CoverPageDocument" xlink:href="ptct-20200717.xsd#CoverPageDocument" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.ptcbio.com/role/CoverPageDocument" xlink:type="extended">
    <link:loc xlink:href="ptct-20200717.xsd#ptct_CoverpageAbstract" xlink:label="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5F215370287B5B7DBC0A90CEF1156655" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_DocumentType_5F215370287B5B7DBC0A90CEF1156655" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_FA1E019E7D0D53C399F97458560F9C6B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_DocumentPeriodEndDate_FA1E019E7D0D53C399F97458560F9C6B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1DDB92DF502F5440B5944E0F37A3C5FC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_EntityRegistrantName_1DDB92DF502F5440B5944E0F37A3C5FC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_FCBA22BA1CF15DE8A652609784994324" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_EntityIncorporationStateCountryCode_FCBA22BA1CF15DE8A652609784994324" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_E10299A9C27B509AAA1D616F8C3DB4D8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_EntityFileNumber_E10299A9C27B509AAA1D616F8C3DB4D8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_A84695F313935184A0C191D04F69827E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_EntityTaxIdentificationNumber_A84695F313935184A0C191D04F69827E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_6DC05BCE30565BAA8292BE951FDDDD74" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_EntityAddressAddressLine1_6DC05BCE30565BAA8292BE951FDDDD74" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_43C5E8CBD19C5308B80567C9E3CCC790" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_EntityAddressCityOrTown_43C5E8CBD19C5308B80567C9E3CCC790" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_BE97AEC212F650519C4C4F3C7A3C9D62" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_EntityAddressStateOrProvince_BE97AEC212F650519C4C4F3C7A3C9D62" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_85EB4064504758E9BB7C62892908B760" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_EntityAddressPostalZipCode_85EB4064504758E9BB7C62892908B760" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_519CE492CA8650C58BEB057A1E345973" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_CityAreaCode_519CE492CA8650C58BEB057A1E345973" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_57780AC224765909A105821B1B7B334A" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_LocalPhoneNumber_57780AC224765909A105821B1B7B334A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_665ED0B097AB54B28C7E52E1EF69F5DF" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_WrittenCommunications_665ED0B097AB54B28C7E52E1EF69F5DF" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_749E45849AF25442841169D3147AD19F" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_SolicitingMaterial_749E45849AF25442841169D3147AD19F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_603F63842A045E0FA8AE0AE8EBA52798" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_PreCommencementTenderOffer_603F63842A045E0FA8AE0AE8EBA52798" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_0DDAF72504015082A4DA8B036BFB4040" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_0DDAF72504015082A4DA8B036BFB4040" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_61CCFF7A09715A84B6CC0379F1171755" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_Security12bTitle_61CCFF7A09715A84B6CC0379F1171755" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_F77B6C56343A58DDA2587B9BC15A9E82" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_TradingSymbol_F77B6C56343A58DDA2587B9BC15A9E82" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_58B4508CE80F587FA1011C043DA9164B" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_SecurityExchangeName_58B4508CE80F587FA1011C043DA9164B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_9680654BD43050C3A3B67BB10D25D0B4" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_EntityEmergingGrowthCompany_9680654BD43050C3A3B67BB10D25D0B4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_18FCE9B3BA665004BEF068674A12C68F" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_EntityCentralIndexKey_18FCE9B3BA665004BEF068674A12C68F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_DA3C3D9CDA815E978D5AA2B68E622AD4" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ptct_CoverpageAbstract_649CB077891E5ACD9EA06BD6E9D2950B" xlink:to="loc_dei_AmendmentFlag_DA3C3D9CDA815E978D5AA2B68E622AD4" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>a20200720ptctroyaltyd_image1.gif
<TEXT>
begin 644 a20200720ptctroyaltyd_image1.gif
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M6OB<6_B=6_B>7/B?7?B@7?BA7@
M                                                 "'Y! $
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MYHE5R$RF,I<Y&&^ZDYOCC*<\YTG/>MKSGO@<)Q/VR?]/?I8S?NQ\23K5N<Z
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M$2S!$ES!'P1"%HS!(23"(G3!+T#")%3")61")60G&KPW\RL\-.LB';RN()Q
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M>Z677Z[[S:&'>_KS>\=>_?79#QZ(]]\?7ZKOY;^1?H##AZ[^O.5&WW\AVA=
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M[_-R'_WM18]ZW>^>]ROP_>^!K_HD+*7UKC<M[-$F^\C23NNX=_[B>1]]Z;,
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M&(\)^>@7C6<)*=N+*9(5W9&C3:B=A4X&M6&44H;689567HFEATIN>>2)7IH
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0J(5;R(5=Z(5?"(:$%Q  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>a8k72020_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ptct-20200717.xsd" xlink:type="simple"/>
    <context id="D2020Q3RPI">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001070081</identifier>
        </entity>
        <period>
            <startDate>2020-07-17</startDate>
            <endDate>2020-07-17</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="D2020Q3RPI"
      id="Fact-C90D3AE434D55A5D8BAD4A46F5CA0987-wk-Fact-C90D3AE434D55A5D8BAD4A46F5CA0987">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="D2020Q3RPI"
      id="Fact-1642947DED3D5B2291908E3083316879-wk-Fact-1642947DED3D5B2291908E3083316879">0001070081</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="D2020Q3RPI"
      id="d83763232e68-wk-Fact-B11A5479A2DF5921BE45362E4144884E">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="D2020Q3RPI"
      id="d83763232e82-wk-Fact-4E2435078FEF5A058D3DB89755B967AD">2020-07-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="D2020Q3RPI"
      id="d83763232e85-wk-Fact-EFEE3054F80A581187EFE81E76F7674A">PTC THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="D2020Q3RPI"
      id="d83763232e109-wk-Fact-1EDA72515FDF5618AAF66F6DDCDEAC28">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="D2020Q3RPI"
      id="d83763232e119-wk-Fact-1990F259F78F526A87FC14D99ADCAE1D">001-35969</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="D2020Q3RPI"
      id="d83763232e129-wk-Fact-28D7768CF45A535298E28FE6C8E4F98C">04-3416587</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="D2020Q3RPI"
      id="d83763232e181-wk-Fact-55CBF53835425A01A4976AD8310E4894">100 Corporate Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="D2020Q3RPI"
      id="d83763232e202-wk-Fact-D5AFA703FDD35DD3961429381F2A40EC">South Plainfield,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="D2020Q3RPI"
      id="d83763232e207-wk-Fact-B18623E59D4F56E3AB06E6156895C9B1">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="D2020Q3RPI"
      id="d83763232e217-wk-Fact-F4579CEAE9145C54AAB13594F5A29D5F">07080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="D2020Q3RPI"
      id="d83763232e244-wk-Fact-389891E702785EDB86EBA778A544C2EE">(908)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="D2020Q3RPI"
      id="d83763232e248-wk-Fact-FB30F253968359D08E1499D8C14E73A1">222-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="D2020Q3RPI"
      id="d83763232e269-wk-Fact-463F07D7FE795C69808165E05B9C1DA3">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="D2020Q3RPI"
      id="d83763232e279-wk-Fact-F9DB1736FA3C5DA6A2F0893C14B33ADC">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="D2020Q3RPI"
      id="d83763232e289-wk-Fact-1656851AA8415AF78E4CD008246CC82C">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="D2020Q3RPI"
      id="d83763232e299-wk-Fact-A77CA685D40750FDB5C79BF4F88086B4">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="D2020Q3RPI"
      id="d83763232e341-wk-Fact-49094D55799A5796A424D6AE1C1FC172">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q3RPI"
      id="d83763232e346-wk-Fact-13CDABD9EC2B5DEE860325B10C6CB1B7">PTCT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q3RPI"
      id="d83763232e351-wk-Fact-3CBBB0143C9256BFAF13A4E61C68CBAC">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="D2020Q3RPI"
      id="d83763232e361-wk-Fact-AE7FCE6B39E55E688E1916F734727D5E">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140665038411464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page Document<br></strong></div></th>
<th class="th"><div>Jul. 17, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ptct_CoverpageAbstract', window );"><strong>cover page [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 17,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PTC THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Address, State or Province</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Contained File Information, File Number</a></td>
<td class="text">001-35969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3416587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 Corporate Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South Plainfield,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(908)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">222-7000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PTCT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001070081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ptct_CoverpageAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>cover page [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ptct_CoverpageAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ptct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M]@5X'BME#@U[(*W^3QC_"U!+ P04    " !=//10@ZFE ]0!   R!@  #0
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M2Z@P0/FFHE%Y;:O8<M(=O<[T_F'RJ*VTSJV4>P^O9,LQ\/A9RQ]02P,$%
M  @ 73ST4"0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>
M+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2
M*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+B
MRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#
M!!0    ( %T\]%!ED'F2&0$  ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM
M;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL
M>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE
M@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J
M1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;
M&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=
M560C2&2FKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^Q
MO-9.&G_FB^$_7G\!4$L! A0#%     @ 73ST4 =!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !=//10
MNU47K^\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " !=//10F5R<(Q &  "<)P  $P              @ '-
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( %T\]%"N+(Y11P0
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M2P$"% ,4    " !=//10)!Z;HJT   #X 0  &@              @ '9$
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !=//1099!Y
MDAD!  #/ P  $P              @ &^$0  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"   ($P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="a8k72020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Page Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ptcbio.com/role/CoverPageDocument</Role>
      <ShortName>Cover Page Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="a8k72020.htm">a8k72020.htm</File>
    <File>a2020-07x20ptctroyalty.htm</File>
    <File>ptct-20200717.xsd</File>
    <File>ptct-20200717_cal.xml</File>
    <File>ptct-20200717_def.xml</File>
    <File>ptct-20200717_lab.xml</File>
    <File>ptct-20200717_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "a8k72020.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "ptct-20200717_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ptct-20200717_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "a8k72020.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ptct-20200717_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ptct-20200717_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ptct-20200717.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ptct",
   "nsuri": "http://www.ptcbio.com/20200717",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a8k72020.htm",
      "contextRef": "D2020Q3RPI",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Page Document",
     "role": "http://www.ptcbio.com/role/CoverPageDocument",
     "shortName": "Cover Page Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a8k72020.htm",
      "contextRef": "D2020Q3RPI",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Contained File Information, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ptcbio.com/role/CoverPageDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "ptct_CoverpageAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "cover page [Abstract]",
        "label": "cover page [Abstract]"
       }
      }
     },
     "localname": "CoverpageAbstract",
     "nsuri": "http://www.ptcbio.com/20200717",
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001070081-20-000122-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001070081-20-000122-xbrl.zip
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M3>MPR3#&G;F"J$2C!.C$CX)<OA9KD@$8*&0,-,C0G]PIL)_<J0!JQV&CBP3
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M%9(1T^P,UL-QY;*UQ7GC03A6?HAEQ)UI6A3I$J=^J)X5Z8H_0&R!]HSFR7E
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MFI7XZCFNX^IC6S-LQQJ/!DY_//!LV_$LTQP:XT:9&=HM'H#8+K!>N)KS\H#
M^N-2^@E%=8:YK:J;#'J800);#7PD=Z0Y8]UTW9$SU,VQW?,:1L+;%)CH"H_J
M4 A_?S]-8 W#Z-B:IGVZTHY#6#E>II! ?9D6Q%^M8A!:P-?'OP6@\4F:P=F)
M\I2,B)]".P%+S[ R)9G3D-R@34G>^GDA2M">L5:%16_J02H30R>?8+^2TN^O
M N[A@@8?6"4CT%>6KK(( Q?3](%,*>AE/"=LQ.,C3N=G,HMBE,-13O"]RP!+
MB 62>;1<QX6?T'2=QQN2^T64SS9LI!B03F$?/*@I*B>S2O*3-<R3$:Q>$FVS
M-(;%<1S6/428,\C)BS\B!5CW\PCLR2B ;>>4?K3^(#_1A&9@55TD /^:EX9Z
M7:/+4?;R_#C(X(#([V]3N&:_-]'LD3T9V^ (]EU'<_2^-=:L@3O41UZO+O)_
M!93 N6,N9YV(,'7^^%H6O&XT]>%P"R"Q%GKU@ YC\@NL )J4O+MA=IUKF^:K
M3ZLA=M3DXT9:?"#YZ#I8&"SP"(BK(Y*L:E7'U^N8$M.P!'OL5!MCD?$+W2;#
MR34Q>EH7.AZ)W#Q >+7[71-W--#M7G_B]8;6R.M[QD1SW!Z8&H->SQLUXD,W
M*7 N;#V9OP,)A>3QG>J>O.H6B60IL+A/<KKI=W2C1G6-PO:*YDRMRWM^'63G
MU*\56GW'TCW/,77+F]C.V!R.-,TQS/YPZ!@-LKO**,HZO-3'[H^@RLO B6XQ
M=K^3GVI50&8GJ&'SH/33S;!CO)B^?!PQ\KY?!SFZ6W($9W+H 4&.3,VVM,EH
M8 UM=S Q)PXHXO[ ;"''BSQ?T^P[47Y>HNS1CODB>!Q1BK[/393/X736C UN
MJ],,K/V5[%X4XU%ANP,*GF !_UD+#ERWV]?PTST__*&J@][!J@-3_T%=<^"H
MV^KCCB6Q^6P1%K9&2 -1BGC..!M)"2:_Q5=(\/MPP8($L9_GWVYP^6F8R7P6
ME+W9+*'OBZ-)*GQIO)17LAC!T%(U@)R\7T3P9"M,C[B&X--% A]A#?7,;8&.
MZ6HNOKG$=ET/_NA[IF&.^MY8'^J3H6X;#9^0:ZB-;DP9EZKCSV@TP0'<%&GP
MX93\7>MJFDY6?D;N_'A-R0K?KK$X^BLU7^Y\^EOGJ3<<>8.1.QX: VLT'CM]
MK6=8 UT;]H<#?6#7ST<(""X?U(=S=3N\_8YX*>*M+6/TAH/!0-/-WM UK/Y@
MXDWTGF>.^_JP[PP'WE#&&*5=VGHI=\\U0)%5WC6[]//0_YW\%*?@+(#!%X/)
M1][YV0?ZA,*VSY*3_#1V\,F;BR1$VY^2Z88$+#H.-MP'D-V4W:G8"5U'.8'Y
MP7% ,V].YEEZ7RS0A5B)R[@AG<'.V%5<'M#3+,F[ [:O#.B1%YC!ME^QH%[9
M&9:!DUSA15[,IG _Q)AVC$>^AZ":%'V2[;C:M-UC]U!.WHSE6.8)__T_'Y__
M[/6W;.:-[<EPW!_TW+%EC?N.,]9=O3^Q>Z9MV"-KO%^M4H+U$X-*W,/^)ASQ
MXR6%BUD+VV'!@)2'H[W,TP(XE,DTX- D94[M.J>L%P M\EOX$L^(.;K\Q55X
MA&RM>(.+LV^Y(K<GX!5"2T;OHAS& =_[28"'Y@?L!:C8&5\]'OI9F//,5JCR
MJ'LO_,JCKC-T5T7MAT,@O\+Z>#"YY"[6XT_\V7*ENR_(^G)OZUIDVW##G':F
M&?4_=/P92,ES/[[W-SGZQ8NL^3(RTQF (=37>YHQLC">-S0LN^_IKJ7I]MC6
M<,Q7_S(R9X>]'0EWHU#KP+,,I.EYOEX"YVV>)3YU4= ET;N:WB5DC-?J,26=
M$I^4"2(R0MT;L;HW;YY1%M[[ WJN_SRR['U"&N^..27LM2?0VU_1-5BX^2G>
ME.R2%R@,L$S*T%X-2]T'O_17+T\)Z!:";]Z$KK#[)0U9(G_"9! EM]DZ+] (
M8(.A[W8@R*-3)M%P]CA:1@672:LT!V,BIP4V@H0# X:5"92(A"73C1\7&W(%
MGM/2)U=OAZ>$6<?,W&%'47599R##\MHY-':C[E;""6=<?R,3CE4/.F7MY1M1
M<B 7%KP%#)E&%TRL'QJ+>WD.QPDP5Q/ZF_K2I1BNH9S5J?%O9</$&0THTECN
MQS3OX,=90I*)N59\KERVW>T"";E/LSB\!WT 6J3@,[%W,J6@OFHKYF&TBOTE
M*H]P#>8='!ZOFV"V:?FTOM85?Y97BX7TCL;I:D?QX(BW$3@W@$><=(A!R*F(
M;BA.K>R_=UBG)&3?&??9'B[3.XK58<3H(8'K^BFJ908Y^.3S.FY/R:1+_I'.
M9DL_Z;SU^?;)VR+LGNX_%CR1SKEASM2P8OCI%O,"GT^C??:^_"CA='6S J:*
MR;MU'JQC/R->D:6KQ89,0,>''%]U+-V\\VI-U3'4DOK0 4YNGOG+4Q$B0J^"
M!(TCD."*;P\164ZS7:<+Z$$3- >2$C.4^T3BJH+U"MK/N4!9^5'8X*6_]RVM
MJQ$0:#%."3(A\/-%<Z$NRJYJQ#UT!0XI?.CK$\ON:GW[!U)^M+V4*N7RC"I@
M (49TR48ZHS)\CJ7<0MN"?.Q^J 4WP2,PAZL.CB.(LWX+)R% %!8!6M)*T;<
M(GZ/?DOT2T;1W]=HR&&-U$.$N7,0V'\WM08JN'B$R?!-R5WR!\SH9](TOU1;
M;Y.=B+V($4\BK%'&6A%@X9&D4Z<8M+"9SN"%8M6KJ=C[I/$\V9'/9A%[23[\
M#D!<@-*"U=BR0"4KC#D(&44?:!: >8U0($2"/EH/=5L^W"K&?7SS\BE9IF$T
M ^[RV?[0H$=]"BQ?4/D"<-*W\@T+CZ*"^7$ (_)Q(A!B">OC%Z >UJ#$IKC_
M%?=6$.#PCF8Y4F($2R..:B<KF+T4_SM +M$<\.,<@$M +@1\:[C1O#S??;A@
M8R@4P!S.T\2?PKH9L 5P2EY2/W]3($S@$[2:@964DX$*X/(KS:3BB]RLI[_5
M#I[7%/I!64(8T(S)%"#3D#EG,KK##6Z)#Z74.BXX7>%.8&E$&^!76$2,(,(H
MJ]/]#@'NDH^"((L*LZ<8 F*4!;(CQWL8G.91@K$=H"R,T0=%"8,UF+"SS2/H
MI(FC"A]PLBG:W)AYH"L59AH$.F>^L$]R$39LB.>HR/?$M83)ZL16GNG*+]B;
M(P5*D)"1NZ64V6(ILF/$< KL#W/1*P %GHO\/.+RWL]P"Q&%K6[E![9PPPB$
M35I$S";9%I36!4.45%_I*,'%T;#HC+]#&P0Q,E55Q8H+59AFFA6C!)P\\RJX
M!D)CG='#.V1*<BMF^AH84)N\5@;+F(N]CS,K62IDKWHIDTJ<EW#)E,1@*6 _
M#BRG_:7_@3*I4FDT,4T)E<H8K!V#,#1V%@8^0HH2ZADP#FIS*I1BL8#!9 %$
MC#Y!J2I_Z=YT28C63<8D1\EAAQ3+\;EN%[-3B>@K#[)6[-PB_W@P*8'A$9:@
M(.],-PV&Q1Y-1Z JWBNE;%;R&E 6R!(,%I7'5<X2(0=2#FQZGW!"\F&JWU+&
M\SOTP-V8E!N1 /N:1:Q^HW4*IR)]MC-T=V4D#Y0TC!?O458RJ39'2O%)F1Z=
M,1;/TK@IK1AK+'QTKU(P/L(H#\":5$EGG")*UC1D53PHF>' _],XBDI([5*\
MX/LJ+M<4^&2]@CGR-6#[,><+/']1)PPF_':.@TG?YSZ-4R2.:+9W((>/ -P=
MMN>C(.=3\D)_J2 ,?LT@RXNM+5<_??H9CYW1_@OCY2[&PY3R\^8)M%8(N>O5
MW%ZU,6Z<-.;^@MNMJ]#IIE*S[*8>^-.\-YQFOIZ6OQC7(MG!XV6:(;11%F(N
MGB6O]C;CEUOA+(2DFT[1$L @2\WE0\\,Z/\).N(3R/];3O"P;=QR2$$V1:LZ
MQEIT?D42+-Z0L0.:4IY7H,)&!"&!?F?U,E^TQ= : 0FX0817'QS9RC\QFGUG
MY" 0I</+B&W*+NOPL TF5QX6T312VKT %[Y7F#D!#'S8-+LEI&N=?U6QAAF(
M:^!KT1E@9Z3RSS6<?T_CX<[N1_C)+)5O?J8Z2(PS\QR+S8+-UYSJ\)0G(S*"
M'<9ISLR\C]N(+(C^"</*AE:&E9OJ)T<MZ9,5NRV>@5Q"RHA*LRY"49: /Q90
MKLQQD^PBUR&:ZA(/R'!5J;"=!8"VBL+'#^IRRH('0_;9Z/+V7T5(>-WL!>M0
M!N]8>Q5!\S'5S6G4=;MZR3!1]5)!6*+!(RPFS29DJ0-VFD=U9"A.ZIY((_B.
M:OPI6ZO+YCJ>3K'2"=@=10^P?(BG%@KA(Q#-Q(# ,V/E*B0*9UJE*)U'UAZ<
M,H&RY,G4>F2TWGD;DX7EMH9BW@P"Q)$/KD5E'X$^R#DT/&K5V-@!9"$3E(E@
MCFQ\R0F3S"4$(*+Y%P*$7%3>PRHK-]+]:O!3X88C#CAX/(B#3($W):L3!@A%
M<"QH@,J5,;]%^?$.T&,2=_52ZE[_.:_%?JVIWF/)V#ZI>GVO'$-6L]%6XD[V
M 945FMM&XQ5UCZYG!;A.GH3:O3L GRZ;[#(%_Y2B0X#^U0'P/X>-,JEJ36Y*
M,<8C6$+R[\9.]LORCK'*![^S4V[@^_<K/LV]$ZOKN([Y&2Z>Z+;Z<DE?W63;
MQW?OY-G8MK3++E,9?WX3N_[V7\@D.=?1-A+PI[CC@7[%D1SPG^B-8@H&]1M=
MI7>40(RGV?G?-/AO,FE6[(FPSZL3PC^(ZXLONCX8&GX;5]0U=1?%\F-0><6"
M =<\&%"6">V$*41H APB>1U<=1"^Q!IX!ODE,\N_33;6-?-(J/P[%W]4\(AG
MU]&5);,L71X*KYV*RP@%CRY?)"@<R+\'UV\_U26>9PLA2%>TS<^4^96H_"$8
MV2!DL1R@<L'(,$T"FK%"-<#YO9^%Y&V:?F"79BL_[:,NRW\ZJHGRDC*J$HL9
MA[43"UCSK4^)Z1N1\5Y2/Q$1X5N6<8KNL#*@%AM["W^)EWY=4R2U;;0,_!#B
MQ7%]:K$\I\5B"]>IB,85"Q^?I[S6!MJ+-$-N)5@5=(JOAFP!O!X-K:V)M7H9
M/CSGZ8HUUFN((JNRSF,5^Z+,! MXL"6O\ALBG/X*:['\\@42S7KA_\[);VG$
MWBM1K^<4%9^XUYMW7N,=EUBE(2MKS-=3\0$5@$J2^V)U-]OLV1;<5SOPL)@G
MG6].RPUCS5&Y7?%H>WMEE?+;+U53ABGM-:UP\ANO2 O2?&>I6I&4J%I;\\.#
M00&E85Y*J5I9>56=]:J.!&9U1.623ZWY?%65)*0LG!S=\5 V.-(@*EG20ERB
MX=]-:J'_I;]AP67QG0YNI^#,]RE>ZA&1[?DZ"I$<1%2[*C]&4CHM ^OB&=8M
MX5MZ"[K;,J5Q!*C>?0R;8Q6H>\\9DG>?\M?T[3Z%;>P^*OQL3O>&5[C>;<"4
MX=XSK%+<?1C('N8+>5=>O5$]9X<:P8'Z61DT1R(M3^M60FH^KZ.#KNL8V1XH
MFRDY48O@!PO$:2EQL*HRC/#-.541 MBB@BI1THA5L?@BPS++6!QY"XF /X_5
M5CE+>PA >'7'G9]%E"<OLBC_P*D94VRL=(^7K]6+51& C,:BAHN+*)ID($=X
M\A9K']>!*-D5.\;)\P)FH+F\QIQU9D4I.0E!4B=SEG-I LN3A>4\HG*/(0O
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MB#V494QF,12,3RZ-W49A<LI9348S$=XYOS"53KK+K2R>;&\8[OT#4$L#!!0
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MM6SK)GS>R:!8,O"1=_7_?EQ/LNEPO1C]ZG]B: B%7$NB!0$4I0XC35<C6A/
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M"6"$ L*I<%)KOZ5 0B+IM<K92Z]DEN$2G^[IVR"=4HQ43G\ VPDGE%WGNMD
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M1YI$H@4CZ( 9\=,(]AK^BW1],@\P9%?9_3SH!5S8HY,H09BD,8988@H%4<!
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MQ@  #               @ $*$   83AK-S(P,C N:'1M4$L! A0#%     @
M73ST4!2]YC:H P  71(  !$              ( !SC(  '!T8W0M,C R,# W
M,3<N>'-D4$L! A0#%     @ 73ST4 _?C_\\ 0  @ (  !4
M ( !I38  '!T8W0M,C R,# W,3=?8V%L+GAM;%!+ 0(4 Q0    ( %T\]% Y
M1%'6H $  -(%   5              "  10X  !P=&-T+3(P,C P-S$W7V1E
M9BYX;6Q02P$"% ,4    " !=//104U2T[K,+  !D9P  %0
M@ 'G.0  <'1C="TR,#(P,#<Q-U]L86(N>&UL4$L! A0#%     @ 73ST4*NS
MU(J=!@  =34  !4              ( !S44  '!T8W0M,C R,# W,3=?<')E
:+GAM;%!+!08     !P ' ,T!  "=3      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
